Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
May 23, 2005
Finance
U.S. investment in Europe
...Partners; Sofinnova Partners; Auriga Partners; Credit Lyonnais Speedel Switzerland $40.4 Not disclosed ProStrakan U.K. $40.2
LMS Capital
...
Read More
BioCentury
|
Nov 1, 2004
Finance
Ebb & Flow
...in-licensed from Cellegy (CLGY) (see BioCentury, July 19). The round was led by existing shareholders
LMS Capital
...
Read More
BioCentury
|
Oct 25, 2004
Financial News
ProStrakan raises L22 million
...ProStrakan (Galashiels, UK) raised L22 million ($39.6 million) in a venture round led by shareholders
LMS Capital
...
Read More
BioCentury
|
Jun 14, 2004
Company News
ProSkelia SA, Strakan deal
...Roland Baron will become president and CSO. Investors in Strakan include Warburg Pincus; 3i; and
LMS Capital
...
Read More
BioCentury
|
Jun 8, 2004
Top Story
Strakan to merge with ProSkelia
...and Isotard isosorbide to treat angina. Investors in Strakan include Warburg Pincus ; 3i; and
LMS Capital
...
Read More
Items per page:
10
1 - 5 of 5
BioCentury
|
May 23, 2005
Finance
U.S. investment in Europe
...Partners; Sofinnova Partners; Auriga Partners; Credit Lyonnais Speedel Switzerland $40.4 Not disclosed ProStrakan U.K. $40.2
LMS Capital
...
Read More
BioCentury
|
Nov 1, 2004
Finance
Ebb & Flow
...in-licensed from Cellegy (CLGY) (see BioCentury, July 19). The round was led by existing shareholders
LMS Capital
...
Read More
BioCentury
|
Oct 25, 2004
Financial News
ProStrakan raises L22 million
...ProStrakan (Galashiels, UK) raised L22 million ($39.6 million) in a venture round led by shareholders
LMS Capital
...
Read More
BioCentury
|
Jun 14, 2004
Company News
ProSkelia SA, Strakan deal
...Roland Baron will become president and CSO. Investors in Strakan include Warburg Pincus; 3i; and
LMS Capital
...
Read More
BioCentury
|
Jun 8, 2004
Top Story
Strakan to merge with ProSkelia
...and Isotard isosorbide to treat angina. Investors in Strakan include Warburg Pincus ; 3i; and
LMS Capital
...
Read More
Items per page:
10
1 - 5 of 5
Previous page
Next page